Advanced Peptide Receptor Radionuclide Therapy to Overcome Refractory Hypoglycemic Insulinoma: A Case Report and Review of the Literature
Journal of Medical Sciences · 2025-09 · 45 (5) · 208-212
DOI: 10.4103/jmedsci.jmedsci_48_25 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical Sciences, online erschienen am 30.07.2025. Verfasst von Yi-Hsiang Huang und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
We reported the case of a 42-year-old man with refractory hypoglycemia caused by an inoperable malignant insulinoma and multiple liver metastases. The patient initially received bi-weekly intramuscular injections of octreotide long-acting release and a daily oral dose of everolimus. Despite this treatment, hypoglycemia was only partially alleviated, and there were no changes in tumor size. As a next step, the patient underwent peptide receptor radionuclide therapy (PRRT) with lutetium-177 (177 Lu)-Dotatate as a salvage therapy. After four courses of PRRT, there was a noticeable regression of the liver masses, and the hypoglycemia resolved. In addition, the patient’s quality of life significantly improved, as he no longer required antihypoglycemic medication or had to endure frequent blood sugar testing.
Zitieren
APA
Huang, Y., Su, S., & Huang, T. (2025). Advanced Peptide Receptor Radionuclide Therapy to Overcome Refractory Hypoglycemic Insulinoma: A Case Report and Review of the Literature. Journal of Medical Sciences, 45(5), 208-212. https://doi.org/10.4103/jmedsci.jmedsci_48_25
Vancouver
Huang Y, Su S, Huang T. Advanced Peptide Receptor Radionuclide Therapy to Overcome Refractory Hypoglycemic Insulinoma: A Case Report and Review of the Literature. Journal of Medical Sciences. 2025;45(5):208-212. doi:10.4103/jmedsci.jmedsci_48_25
BibTeX
@article{Huang2025,
author = {Huang, Yi-Hsiang and Su, Sheng-Chiang and Huang, Tzu-Chuan},
title = {Advanced Peptide Receptor Radionuclide Therapy to Overcome Refractory Hypoglycemic Insulinoma: A Case Report and Review of the Literature},
journal = {Journal of Medical Sciences},
year = {2025},
volume = {45},
number = {5},
pages = {208--212},
doi = {10.4103/jmedsci.jmedsci_48_25}
}
EUVIMED